Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torcetrapib/Atorvastatin vs Fenofibrate in Mixed Hyperlipidemia
NCT00139061Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of torcetrapib in mixed hyperlipidemia (2 arms), sponsored by Pfizer. Primary endpoints: HDL-C increase and non-HDL lowering. Started Mar 2005; status: completed.
02
Drugs
torcetrapib
03
Conditions
mixed hyperlipidemia
Beyond the preview
Go deeper on NCT00139061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139061.